Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference in saving lives. Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. The systems are able to track and analyze more data, more accurately than can the humans. Radiologists receive years of training. They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done. “Artificial intelligence expands into health care leveraging insight from radiological studies and diagnostics. Radiologists have a deluge of patient data that the artificial intelligence can manage in some ways. This contributes to earlier cancer diagnosis.” Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff. Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023. Companies Profiled Market Leaders • General Electric • IBM Market Participants • Alphabet / Google • GlaxoSmithKline (GSK) • Merck • Prognos • Quest Diagnostics • Safeguard Scientifics • Zebra Companies Mentioned • Drug discovery artificial intelligence • Numerate • BenevolentAI. • Exscientia • twoXAR • Berg • Atomwise
Table of Contents Abstract: Approaching Pancreatic Cancer with Artificial Intelligence Diagnostics Vastly Improves Outcomes 1 Artificial Intelligence (AI) Cancer Diagnostics Executive Summary 8 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces 8 Artificial Intelligence Cancer Diagnostics Market Shares: 9 Artificial Intelligence Cancer Diagnosis Market Forecasts: 10 1. Artificial Intelligence Cancer Diagnostics Market Description and Market Dynamics: 12 1.1 Artificial Intelligence Very Big Breakthrough in Cancer Diagnostics 12 1.2 Ability of AI Solutions To Discover Schemas in Large Databases 13 2. Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces 15 2.1 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces 15 2.2 Artificial Intelligence Cancer Diagnostics Market Shares: 17 2.3 Artificial Intelligence for Cancer Diagnostics Market Forecasts: 18 2.4 Cancer Statistics 25 2.5 Hospital Artificial Intelligence (AI) Challenges 28 2.6 Hospital Artificial Intelligence Software Prices: 33 2.7 Hospital Artificial Intelligence Regional Segments: 34 3. Hospital Artificial Intelligence Products: 36 3.1 Partners HealthCare, IBM, and GE Healthcare 36 3.2 IBM Watson 38 3.2.1 IBM Genomic And Immunotherapy Supercomputing for Patient Management 41 3.2.2 Mayo Clinic and IBM Watson 42 3.3 Google’s AI Subsidiary DeepMind is Partnering With Another UK hospital 44 3.4 Prognos 44 4. Hospital Artificial Intelligence Research and Technology: 45 4.1 Research at Google 45 4.2 IBM AI Research 46 4.2.1 Neural Representation of Sketch Drawings 47 4.3 Google and Nvidia Artificial Intelligence 48 5. Hospital Artificial Intelligence Companies 49 5.1 Alphabet / Google 49 5.1.1 Google Artificial Intelligence Subsidiary DeepMind Healthcare Initiative 49 5.2 General Electric (GE) 50 5.2.1 General Electric Revenue by Segment 50 5.2.2 GE Healthcare and Massachusetts General Artificial Intelligence 51 5.3 IBM 54 5.3.1 IBM Watson Genomics by Quest Diagnostics 55 5.3.2 IBM Watson Healthcare Revenue 57 5.3.3 IBM Watson Solutions Software Healthcare Revenue 57 5.4 Prognos 58 5.4.1 Coding Healthcare Datasets Full Of Unstructured Text 61 5.5 Quest Diagnostics 65 5.5.1 IBM Personalized Healthcare: Watson Genomics from Quest Diagnostics 66 5.5.2 Quest Diagnostics Revenue 67 5.6 Safeguard Scientifics Announces Second Quarter 2017 Financial Results 67 5.6.1 Safeguard Scientifics Prognos DxCloud 68
List of Tables and Figures Abstract: Approaching Pancreatic Cancer with Artificial Intelligence Diagnostics Vastly Improves Outcomes 1 Figure 1. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide, 2016 9 Figure 2. Artificial Intelligence for Cancer Diagnosis Market Shipments Forecasts Dollars, Worldwide, 2017-2023 11 Figure 3. Cancer Artificial Intelligence Components 14 Figure 4. Hospital Artificial Intelligence Predictive Functions 14 Figure 5. Artificial Intelligence Cancer Diagnostics (AI) Market Driving Forces 15 Figure 6. Healthcare Safety Features Implemented by Artificial Intelligence (AI)16 Figure 7. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide, 2016 17 Figure 8. Artificial Intelligence for Cancer Diagnostics Market Shares, Dollars, Worldwide, 2016 18 Figure 9. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide, 2017-2023 20 Figure 10. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide, 2017-2023 21 Figure 11. AI Replacements for Supervised Manual Techniques For Diagnosis And Care Delivery. 22 Figure 12. Hospital Artificial Intelligence Long-Term Goal 23 Figure 13. Hospital Artificial intelligence Action Functions 24 Figure 14. Pancreatic Cancer Survival Rate 27 Figure 15. Hospital Artificial Intelligence (AI) Challenges 29 Figure 16. Hospital Artificial Intelligence (AI) Human Factors 29 Figure 17. Hospital Artificial Intelligence Software, US and Worldwide, Shipments Forecast, Dollars, Worldwide, 2017-2019 32 Figure 18. Hospital Artificial Intelligence Regional Market Segments, 2016 34 Figure 19. Hospital Artificial Intelligence Regional Market Segments, 2016 35 Figure 20. Truven Health Analytics Products 40 Figure 21. IBM TrueNorth Neurosynaptic System 46 Figure 22. AI Makes Words Manageable 47 Figure 23. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Workflow 52 Figure 24. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Center of Excellence 53 Figure 25. Prognos Investors 59 Figure 26. Percent Patients with Abnormally High Test 5 years Prior to First Pancreatic Cancer Diagnosis Stratified by Test and by Year 63 Figure 27. Prognos Pancreatic Cancer Diagnosis Test Result Variance 64 Figure 28. Watson Genomics from Quest Diagnostics Features: 66
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.